Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 11:56 am Purchase | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 5,188,265 12.000% | 1,107,166![]() (+27.13%) | Filing History |
| 2025-02-14 11:55 am Purchase | 2024-12-31 | 13G | Cimpress plc CMPR | JANUS HENDERSON GROUP PLC JHG | 3,041,361 12.100% | 194,034![]() (+6.81%) | Filing History |
| 2025-02-14 11:55 am Purchase | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 4,339,254 13.100% | 576,059![]() (+15.31%) | Filing History |
| 2025-02-14 11:55 am Purchase | 2024-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | JANUS HENDERSON GROUP PLC JHG | 14,080,219 14.600% | 753,332![]() (+5.65%) | Filing History |
| 2025-02-14 11:54 am Purchase | 2024-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 4,380,382 7.200% | 193,688![]() (+4.63%) | Filing History |
| 2025-02-14 11:37 am Sale | 2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX | JANUS HENDERSON GROUP PLC JHG | 17,839 0.000% | -4,781,513![]() (-99.63%) | Filing History |
| 2025-02-14 11:36 am Sale | 2024-12-31 | 13G | Applied Therapeutics, Inc. APLT | JANUS HENDERSON GROUP PLC JHG | 35,791 0.000% | -12,069,120![]() (-99.70%) | Filing History |
| 2025-02-14 11:36 am Sale | 2024-12-31 | 13G | PepGen Inc. PEPG | JANUS HENDERSON GROUP PLC JHG | 522,256 1.600% | -1,814,260![]() (-77.65%) | Filing History |
| 2025-02-14 11:36 am Sale | 2024-12-31 | 13G | Immunic, Inc. IMUX | JANUS HENDERSON GROUP PLC JHG | 2,689,082 3.000% | -2,410,196![]() (-47.27%) | Filing History |
| 2025-02-14 11:35 am Sale | 2024-12-31 | 13G | Caesars Entertainment, Inc. CZR | JANUS HENDERSON GROUP PLC JHG | 7,101,885 3.300% | -5,507,358![]() (-43.68%) | Filing History |
| 2025-02-14 11:35 am Sale | 2024-12-31 | 13G | Precision BioSciences, Inc. DTIL | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -702,069![]() (Position Closed) | Filing History |
| 2025-02-14 11:35 am Sale | 2024-12-31 | 13G | NeoGenomics, Inc. NEO | JANUS HENDERSON GROUP PLC JHG | 6,165,063 4.800% | -438,117![]() (-6.63%) | Filing History |
| 2025-02-14 11:34 am Sale | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | JANUS HENDERSON GROUP PLC JHG | 2,252,240 4.900% | -884,847![]() (-28.21%) | Filing History |
| 2025-02-14 11:34 am Sale | 2024-12-31 | 13G | Neurogene Inc. NGNE | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -709,469![]() (Position Closed) | Filing History |
| 2025-02-14 11:34 am Sale | 2024-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -4,809,518![]() (Position Closed) | Filing History |
| 2025-02-14 11:25 am Purchase | 2024-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | JANUS HENDERSON GROUP PLC JHG | 2,080,367 5.600% | 2,080,367![]() (New Position) | Filing History |
| 2025-02-14 11:25 am Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | JANUS HENDERSON GROUP PLC JHG | 690,743 10.000% | 690,743![]() (New Position) | Filing History |
| 2025-02-14 11:25 am Purchase | 2024-12-31 | 13G | Revolution Medicines, Inc. RVMD | JANUS HENDERSON GROUP PLC JHG | 9,483,999 5.200% | 9,483,999![]() (New Position) | Filing History |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | JANUS HENDERSON GROUP PLC JHG | 4,983,940 5.300% | 4,983,940![]() (New Position) | Filing History |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | Avidity Biosciences, Inc. RNA | JANUS HENDERSON GROUP PLC JHG | 7,053,010 5.900% | 7,053,010![]() (New Position) | Filing History |

